Diarré hos henholdsvis 17, 6% og 20, 6%, kvalme hos 11, 2% og 15, 2%, hovedpine hos 10, 1% og 12, 4%, pyreksi hos 6, 3% og 11, 0% af patienterne.
For patients in the ISENTRESS 400 mg twice daily + OBT arm and the comparator placebo + OBT arm, the most commonly reported adverse reactions (> 10% in either group), of all intensities and regardless of causality were: diarrhoea in 17.6% and 20.6%, nausea in 11.2% and 15.2%, headache in 10.1% and 12.4%, pyrexia in 6.3% and 11.0% of patients, respectively.